Cargando…
Optimal multistage designs for randomised clinical trials with continuous outcomes
Multistage designs allow considerable reductions in the expected sample size of a trial. When stopping for futility or efficacy is allowed at each stage, the expected sample size under different possible true treatment effects (δ) is of interest. The δ-minimax design is the one for which the maximum...
Autores principales: | Wason, James MS, Mander, Adrian P, Thompson, Simon G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499690/ https://www.ncbi.nlm.nih.gov/pubmed/22139822 http://dx.doi.org/10.1002/sim.4421 |
Ejemplares similares
-
Group sequential designs for stepped-wedge cluster randomised trials
por: Grayling, Michael J, et al.
Publicado: (2017) -
The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected
por: Wason, James MS, et al.
Publicado: (2015) -
Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes
por: Wason, James M. S., et al.
Publicado: (2012) -
An optimised multi-arm multi-stage clinical trial design for unknown variance
por: Grayling, Michael J., et al.
Publicado: (2018) -
An adaptive trial design for updating the threshold of a continuous biomarker
por: Spencer, Amy, et al.
Publicado: (2015)